Physician profile
Gary Sullivan
NPI 1659334597
$2,908.86
in general payments reported to CMS, 2019-2025
20 companies · $293 in 2025
The $293 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $101 · 2021: $216 · 2022: $683 · 2023: $661 · 2024: $540 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,493.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $959.21 | 2023-2025 | Myfembree, Gemtesa |
| Myovant Sciences INC. | $462.27 | 2022 | |
| Abbvie INC. | $303.49 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Bayer Healthcare Pharmaceuticals INC. | $229.47 | 2019-2025 | |
| Pfizer INC. | $160.87 | 2019-2024 | |
| Evofem Biosciences, INC. | $147.01 | 2020-2023 | Phexxi |
| Hologic Sales and Service, LLC | $135.08 | 2019-2024 | Aptima, Omni Hysteroscope, Coolseal Generator |
| Mayne Pharma Commercial LLC | $114.52 | 2022-2023 | |
| Amag Pharmaceuticals, INC. | $109.34 | 2019 | |
| Medtronic USA, INC. | $52.71 | 2019-2020 | |
| Astellas Pharma US INC | $51.34 | 2024-2025 | Veozah |
| Allergan, INC. | $45.12 | 2019 | |
| Axonics, INC. | $24.50 | 2023 | Bulkamid, Axonics |
| Amgen INC. | $20.42 | 2019 | |
| Therapeuticsmd, INC. | $19.74 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $16.88 | 2019 | |
| Galderma Laboratories, L.P. | $15.75 | 2025 | |
| Millicent US INC | $14.72 | 2024 | Femring, Intrarosa |
| Exact Sciences Corporation | $14.63 | 2025 | The Cologuard Plus Collection Kit |
| Agile Therapeutics, INC. | $11.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.